SCHEMBL5848086

SCHEMBL5848086

COC(=O)[C@H]1CCc2cc(NC(C)=O)ccc2O1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 1/20 0.49
CYP4A11 Q02928 1/20 0.49
CYP2D6 P10635 3/20 0.48
OPRK1 P41145 3/20 0.48
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
MAPT P10636 2/20 0.43
NPC1 O15118 1/20 0.43
RAB9A P51151 1/20 0.43
BAZ2B Q9UIF8 1/20 0.42
MTNR1A P48039 1/20 0.42
CHRNB4 P30926 2/20 0.41
CHRNA3 P32297 2/20 0.41
TSHR P16473 1/20 0.41
RORC P51449 1/20 0.40
ITGB3 P05106 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5848092 1.00 CYP4F2 (0.49) CYP4F2CYP4A11CYP2D6OPRK1NFKB1
SCHEMBL5848084 1.00 CYP4F2 (0.49) CYP4F2CYP4A11CYP2D6OPRK1NFKB1
SCHEMBL6355139 0.88 CYP4F2 (0.66) CYP4F2CYP4A11CYP2D6OPRK1NFKB1
SCHEMBL5847418 0.87 CYP2D6 (0.52) CYP4F2CYP4A11CYP2D6OPRK1NFKB1
SCHEMBL5847422 0.87 CYP2D6 (0.52) CYP4F2CYP4A11CYP2D6OPRK1NFKB1
SCHEMBL5847426 0.87 CYP2D6 (0.52) CYP4F2CYP4A11CYP2D6OPRK1NFKB1
SCHEMBL29588035 0.84 NPC1 (0.50) CYP4F2CYP4A11CYP2D6OPRK1NFKB1
SCHEMBL29588031 0.83 ITGB3 (0.45) CYP4F2CYP4A11NFKB1NFKB2RELA
SCHEMBL29587654 0.83 ITGB3 (0.45) CYP4F2CYP4A11NFKB1NFKB2RELA
SCHEMBL29052788 0.81 CYP4F2 (0.53) CYP4F2CYP4A11NFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034051-B2 Fused bicyclic carboxamide derivatives and methods of their use ADOLOR CORPORATION (US) 2006-04-25 US disclosed
US-20050054630-A1 Fused bicyclic carboxamide derivatives and methods of their use CUBIST PHARMACEUTICALS, INC. 2005-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054630-A1 Fused bicyclic carboxamide derivatives and methods of their use PAICS, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CPS1 CYP4F2 367/4885CYP4A11 742/4885CYP2D6 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.